Question 1) How did Novartis M&A strategy change direction by its incoming CEO Joe Jimenez? Describe the ” new” priorities in Novartis M&A and portfolio strategy
Question 2) Which did Novartis choose for its corporate portfolio review and the assessment of its strategic option for revitalizing the its corporate portfolio